)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Oncolytics Biotech (ONCY) investor relations material
Oncolytics Biotech Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary11 Nov, 2025
Executive summary
Focused on advancing pelareorep as a platform immunotherapy for GI tumors, with ongoing and planned registration-directed clinical studies in pancreatic, anal, and colorectal cancers.
Announced key clinical trial updates, including a planned registration study in first-line metastatic pancreatic cancer and progress in the GOBLET study for GI cancers.
Formed a new GI Tumor Scientific Advisory Board to guide clinical and regulatory strategy.
Ended Q3 2025 with $12,352 in cash and cash equivalents, estimating funding runway into March 2026.
Financial highlights
Net loss for Q3 2025 was $14,400, up from $9,543 in Q3 2024; net loss for the nine months ended September 30, 2025, was $27,252, compared to $23,693 in the prior year period.
R&D expenses for Q3 2025 increased to $7,515 (Q3 2024: $6,794), mainly due to manufacturing, IP, and personnel costs; nine-month R&D expenses decreased to $14,407 (2024: $17,095) due to lower clinical trial and manufacturing costs.
G&A expenses for Q3 2025 rose to $6,325 (Q3 2024: $3,105), and for the nine months to $12,138 (2024: $9,450), driven by higher public company-related costs and professional fees.
Cash used in operating activities for the nine months was $18,620, with $15,401 provided by financing activities.
No revenue was generated; accumulated deficit reached $504,965 as of September 30, 2025.
Outlook and guidance
Plans to provide interim efficacy updates for GOBLET Cohort 5 and discuss accelerated approval for Cohort 4 with the FDA in early 2026.
Manufacturing program to focus on process validation and supply distribution for ongoing and planned studies.
Intends to raise additional funds through equity, strategic collaborations, or debt; filed a Form F-3 for up to US$150 million in securities.
Material uncertainties exist regarding the ability to continue as a going concern beyond March 2026 without additional financing.
Detail SCAC accelerated approval study plans
What is the prioritized funding strategy for 2026?
Update on mPDAC registration study regulatory clarity
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Oncolytics Biotech earnings date
Q4 20256 Mar, 2026
Next Oncolytics Biotech earnings date
Q4 20256 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Oncolytics Biotech Inc is a biotechnology company developing immuno-oncology therapies to treat various cancers. The company focuses on the development of proprietary viral-based therapies that stimulate the immune system to target and destroy cancer cells. Oncolytics Biotech conducts clinical research and collaborates with pharmaceutical and academic partners. The company is headquartered in Calgary, Canada, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage